A new series of tests is now showing that this exciting blood test can screen for numerous types of cancer with a stunningly high degree of accuracy.
The test, developed by GRAIL, Inc., uses next-generation sequencing technology to probe DNA for tiny chemical tags (methylation) that influence whether genes are active or inactive. Get the full story here courtesy of goodnewsnetwork.org